Trials / Sponsors / South Plains Oncology Consortium
South Plains Oncology Consortium
Network · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Phase I Trial of IV Fenretinide (4-HPR) Plus IV Safingol for Patients With Relapsed Malignancies Solid Tumor | Phase 1 | 2016-11-01 |
| Terminated | Fenretinide Lym-X-Sorb + Ketoconazole + Vincristine for Recurrent or Resistant Neuroblastoma Recurrent Neuroblastoma, Neuroblastoma | Phase 1 | 2014-05-01 |
| Unknown | Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophos Recurrent or Refractory Solid Tumors, Ewing Sarcoma, Rhabdomyosarcoma | Phase 1 | 2013-12-01 |
| Terminated | Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer Ovarian Cancer, Cancer of Ovary, Cancer of the Ovary | Phase 1 / Phase 2 | 2012-02-01 |
| Terminated | Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma | Phase 1 | 2010-08-01 |
| No Longer Available | Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma Recurrent Neuroblastoma, Neuroblastoma | — | — |